Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/5/22 16:15 | 4/1/22 | ORTX | Health | BioPrd | Biological Products, (No Diag | Gaspar Bobby | X0 | DO | CEO | P | 11 | 0.7390 | 0 | 15 | 4 | 370 | D | ||||||||||||||
4/4/22 16:15 | 4/1/22 | ORTX | Health | BioPrd | Biological Products, (No Diag | Thomas Frank E | X0 | O | See Rema | P | 7 | 0.7474 | 0 | 10 | 24 | 52 | D | ||||||||||||||
11/6/20 16:32 | 8/10/20 | ORTX | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | T | P.m | 3,563 | 4.63 | 0 | 769 | 8 | 9,881 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |